Suscribirse

Tokuhashi score and other prognostic factors in 260 patients with surgery for vertebral metastases - 21/05/15

Doi : 10.1016/j.otsr.2015.03.007 
C. Eap , E. Tardieux, O. Goasgen, S. Bennis, E. Mireau, B. Delalande, F. Cvitkovik, B. Baussart, S. Aldea, N. Jovenin, S. Gaillard
 Service de neurochirurgie, hôpital Foch, 40, rue Worth, 92151 Suresnes, France 

Corresponding author. Service de neurochirurgie, CHU de Reims, 45, rue Cognacq-Jay, 51100 Reims, France. Tel.: +33 2 36 78 76 59; fax: +33 3 26 78 40 97.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Metastatic disease of the spine is an increasingly common public health problem. Surgery should be an integral component of the overall cancer treatment plan and, importantly, must neither delay not jeopardize any of the other components. The prognosis governs the choice of the surgical strategy. Tokuhashi et al. developed a prognostic score in 1990, then revised it in 2000 and 2005. Here, our objective was to evaluate the performance of the Tokuhashi score in a cohort of 260 patients and to look for other variables that might improve preoperative outcome prediction.

Material and method

We retrospectively established a single-centre cohort of 260 patients who underwent spinal metastasis surgery between 1998 and 2008. For each patient, the following data were collected prospectively: socio-demographic features, history of the malignancy, variables needed to determine the Tokuhashi score, and treatments used. SAS 9.0 software was chosen for the statistical analysis. Variables were described as mean±SD, overall survival was estimated using the Kaplan–Meier method, and survivals in subgroups were compared by the log-rank test. To assess agreement between survival predicted by the Tokuhashi score and observed survival, we computed Cohen's kappa and interpreted the results according to Landis and Koch.

Results

There were 143 females and 117 males with a mean age of 59years and overall median survival of 10months. Median observed survivals in the three Tokuhashi score categories (<6, 6–12, and >12months predicted survival) were 5, 10, and 36months, respectively. These survival times differed significantly (P<0.0001). Cohen's kappa indicated moderate agreement between predicted and observed survivals. Other factors associated with significant survival differences were time from cancer diagnosis to metastasis diagnosis (synchronous, <2years, 2–5years, or >5years; P<0.0001) and age (<70years or ≥70years, P=0.0053).

Conclusion

Our cohort study supports the validity and reproducibility of the Tokuhashi score. Our finding that shorter time to metastasis diagnosis and age70years were also significantly associated with survival in our population invites further efforts to improve and update the Tokuhashi score.

Level of evidence

IV, retrospective study.

El texto completo de este artículo está disponible en PDF.

Keywords : Tokuhashi, Spinal metastasis, Prognosis, Spine


Esquema


© 2015  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 101 - N° 4

P. 483-488 - juin 2015 Regresar al número
Artículo precedente Artículo precedente
  • Prone and direct posterior approach for management of posterior column tibial plateau fractures
  • K.-C. Lin, Y.-W. Tarng, G.-Y. Lin, S.-W. Yang, C.-J. Hsu, J.-H. Renn
| Artículo siguiente Artículo siguiente
  • The effect of laminae lesion on thoraco-lumbar fracture reduction
  • E. Skiak, A. Karakasli, A. Harb, ?.S. Satoglu, O. Basci, H. Havitcioglu

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.